$596.98+40.88% · 3M
Moving avg
1W+1.57%
1M+12.60%
3M+40.88%
6M+40.82%
YTD+4.55%
1Y+29.98%
3Y+124.75%
5Y+245.39%
52-week range
$373.0088% of range$628.92
Company health
Value0/6
Growth6/6
Profitability4/6
Health2/6
Dividend0/6
Bull vs bear
Strengths
- High return on equity (11015%)
- Revenue compounding 22% a year
- Net cash on the balance sheet
Risks
- Trades 16% above the average analyst target
Key statistics
Valuation
Market cap
$16.66B
Enterprise value
$14.70B
P/E ratio (TTM)
30.37x
P/S ratio (TTM)
5.42x
EV/EBITDA
23.98x
Per share & returns
EPS (TTM)
$17.36
Dividend yield
0.00%
Beta (1Y)
1.15
30-day change
+12.60%
Trading
Volume (24h)
289.32K
Previous close
$605.50
Shares outstanding
27.91M
About Medpace Holdings, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Symbol
MEDP
Medpace Holdings, Inc. is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NASDAQ (United States) and trade under the ticker MEDP.
Frequently asked questions
What is Medpace Holdings, Inc.'s market cap?
Medpace Holdings, Inc. (MEDP) has a market capitalization of $16.66B.
What is Medpace Holdings, Inc.'s P/E ratio?
Medpace Holdings, Inc. trades at a price-to-earnings (P/E) ratio of 30.37.
What exchange does MEDP trade on?
MEDP trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 364.30-0.33%
$356.76B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.90-0.24%
$289.73B cap
AstraZeneca PLCLON: AZN
£116.28-0.63%
$243.12B cap